S. 4191 · 116th Congress

United States Pharmaceutical Supply Chain Review Act

Stage
In committee
Introduced
2020-07-02
Latest action
2020-07-02 · Introduced in Senate

Summary

United States Pharmaceutical Supply Chain Review Act

This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.